US drug maker Gilead Pharma says
that the recent decision by the patent office, which rejected patent for one of
its molecules, does not impact its India plans.
Gilead has announced that it is
expanding the voluntary licence agreement with eight Indian companies to
include its experimental drug that could cure all the six types of hepatitis C.
Drug-Induced Birth Defects
Birth defects are abnormalities of function, structure or metabolism that are present since birth. Taking certain drugs during pregnancy can cause birth defects.
Advertisement
The American biotechnology company also makes the new hepatitis C drug Sofosbuvir. Last year, Gilead signed a licensing agreement with Strides, Mylan, Cipla, Dr Reddys, Ranbaxy, Zydus Cadila for Sovaldi.
The drug, priced at $84,000 in US
for 12-week treatment, will be sold at $900 in India. It is expected to launch
the drug in coming months in India, says the company.
Gregg Alton executive vice-president to ET said that, "We believe that Gilead and Indian companies can make a difference to the world through such partnerships."
Alton also said that the decision by the patent office is only for one of the ancillary molecules and the company does not see this decision as an indication of India's policy on intellectual property.
Source: Medindia
Gregg Alton executive vice-president to ET said that, "We believe that Gilead and Indian companies can make a difference to the world through such partnerships."
Alton also said that the decision by the patent office is only for one of the ancillary molecules and the company does not see this decision as an indication of India's policy on intellectual property.
Source: Medindia
Drugs Causing Low Blood Sodium Levels / Hyponatremia
Many drugs can lower your blood sodium levels or hyponatremia. Low blood sodium symptoms are associated with salt level in blood and causes of hyponatremia are decrease in sodium and water content.
Advertisement
 Chemotherapy DrugsChemotherapy drugs perform like 'magic bullets' to destroy cancer cells in the body. | Advertisement
|
AIDS / HIV - Treatment
Encyclopedia section of medindia explains in brief about the treatment for AIDS/HIV
Advertisement
Latest Drug News
The psychedelic market set for remarkable growth, projected to hit $7.2B by 2029 with a strong 55% CAGR.
The study explores whether CDNF could influence the progression of ALS in rodent models and to elucidate the mechanism through which it operates.
Amoxicillin-clavulanate use in acute sinusitis patients is associated with a higher incidence of adverse events.
Professionals advocate for enhanced education of patients and caregivers, and creation of more effective child-resistant systems for monitoring ADHD medication.
In June, WHO raised concerns about 7 Indian cough syrups after complaints from several countries about contamination and health issues.
